We obtained with our protocol numerous pure M1-CTLs which were producing high amounts of IFNγ, TNFα and IL-2, and were able to specifically lyse both MART-1-pulsed T2 cells and melanoma-derived cell lines very efficiently, with a high functional avidity. The gene discussed is TNF; the disease is melanoma.